Literature DB >> 3164686

AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system.

P F Torrence1, J Kinjo, K Lesiak, J Balzarini, E De Clercq.   

Abstract

In an attempt to provide a derivative of 3'-azido-3'-deoxythymidine (AZT) which might be sequestered in the central nervous system and release AZT, the dihydropyridine ester 5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-deoxythymidine, was synthesized in a three step sequence. This material showed potent anti-HIV-1 activity in MT-4 cells most probably by hydrolysis to the parent nucleoside, AZT. This dihydropyridine derivative of AZT could be easily oxidized to a positively charged pyridinium derivative of AZT in rat brain cytosol. In turn the pyridinium form could be hydrolyzed, non-enzymatically, to AZT.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164686     DOI: 10.1016/0014-5793(88)81319-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  The effect of dihydronicotinate N-substitution on the brain-targeting efficacy of a zidovudine chemical delivery system.

Authors:  M E Brewster; E Pop; A J Braunstein; A C Pop; P Druzgala; A Dinculescu; W Anderson; A Elkoussi; N Bodor
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

2.  Hybrid pharmacokinetic models to describe anti-HIV nucleoside brain disposition following parent and prodrug administration in mice.

Authors:  J M Gallo; J T Etse; K J Doshi; F D Boudinot; C K Chu
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

3.  Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue.

Authors:  R H Lupia; N Ferencz; J J Lertora; S K Aggarwal; W J George; K C Agrawal
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. 1. Effect of probenecid.

Authors:  R J Sawchuk; M A Hedaya
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

5.  Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.

Authors:  M C Maillard; O Nikodijević; K F LaNoue; D Berkich; X D Ji; R Bartus; K A Jacobson
Journal:  J Pharm Sci       Date:  1994-01       Impact factor: 3.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.